EWC vs IBB
iShares MSCI Canada ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.50% for EWC.
- • EWC pays a higher dividend yield (1.30%).
Side-by-side metrics
| Metric | EWC | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.50% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.30% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $5.96B | $9.09B |
YTD return | 7.99% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.80 | 0.69 |
P/E ratio | 20.96 | 24.89 |
Last price | $58.38 | $197.34 |
Inception | — | — |
Issuer | iShares | iShares |
EWC top holdings
| RY | Royal Bank of Canada | 9.68% |
| TD | The Toronto-Dominion Bank | 6.74% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.69% |
| BMO.TO | Bank of Montreal | 4.07% |
| ENB.TO | Enbridge Inc | 3.96% |
| BNS.TO | Bank of Nova Scotia | 3.59% |
| CM.TO | Canadian Imperial Bank of Commerce | 3.54% |
| BN.TO | Brookfield Corp Registered Shs -A- Limited Vtg | 2.85% |
| CNQ.TO | Canadian Natural Resources Ltd | 2.76% |
| AEM.TO | Agnico Eagle Mines Ltd | 2.64% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EWC
EWC (iShares MSCI Canada ETF) is Canadian large and mid-cap equities. Managed by iShares, the fund carries $6.0B in assets under management, an expense ratio of 0.50%, a dividend yield of 1.30%. Its largest holding is Royal Bank of Canada (RY), which represents 9.7% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.